Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue
05/01/2021 13:00
Jan 5 (Reuters) - CURE PHARMACEUTICAL :
* CURE PHARMACEUTICAL RECEIVES FDA APPROVAL FOR ITS IND
APPLICATION FOR ERECTILE DYSFUNCTION PRODUCT CUREFILM BLUE
Source text for Eikon: ID:nBw330Ln2a
Further company coverage: CURR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenir Wellness Solutions
See all newsBrief: Cure Pharmaceutical Reports Q2 2022 Results
Brief: Cure Pharmaceutical Announces Rob Davidson As New Chairman Of The Board And Appointment Of Rob Costantino As Member Of The Board And Audit Committee Chairman
Brief: Cure Pharmaceutical Holding Q1 Revenue $1.5 Million
Brief: CURE Pharmaceutical Augments Its Existing U.S. DEA License
Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue